Golden Eye v Telefonica: Media CAT revisited

No items found.
21 November 2012
Tags
Litigation

The Journal of Intellectual Property Law and Practice has published an article by partner Gary Moss about Arnold J’s decision in Golden Eye v Telefonica.

Media CAT v Adams, decided in the PCC, raised the lid on how the Norwich Pharmacal jurisdiction might be open to abuse in the context of alleged infringement of copyright works by persons who might not be familiar with how the law operated and where those against whom disclosure was sought would probably find it easier to provide that disclosure rather than contest the claimants' actions.

Those issues have now been the subject of further consideration by the High Court, albeit with the advantage that the issues were being considered before the Norwich Pharmacal order had been granted rather than after the event as in Media CAT.

This article examines this latest decision and looks at what it might mean for the Norwich Pharmacal jurisdiction in the future.

To read the JIPLP article in full, click here.

Related articles

EIP recognsied for strategic leadership in patent law at the Professional Services Management Excellence Awards
26 March 2026
EIP has been recognised with two Professional Services Management Excellence Awards 2026, including Excellence in Strategic Leadership and Best in Theme: Leadership. The awards reflect the firm’s commitment to aligning patent expertise with commercial insight, strengthening leadership across the firm and delivering patent strategy that supports investment, growth and high‑value business decisions.
EIP promotes Callum Docherty to Principal in the US
19 March 2026
EIP is pleased to announce the promotion of Callum Docherty to Principal, recognizing his substantial contribution to the firm’s international patent practice and his leadership within EIP’s growing US team.
EIP announces the promotion of Rob Barker to Partner
12 March 2026
EIP is pleased to announce the promotion of Robert Barker to Partner, recognising his significant contribution to the firm’s Digital, Chemistry, Life Sciences, and multidisciplinary patent practice since joining in 2014.